AG001K1T

144701-48-4 | 4'-​[(1,​4'-​Dimethyl-​2'-​propyl[2,​6'-​bi-​1H-​benzimidazol]​-​1'-​yl)​methyl]​[1,​1'-​biphenyl]​-​2-​carboxylic acid

Chemical structure of 4'-​[(1,​4'-​Dimethyl-​2'-​propyl[2,​6'-​bi-​1H-​benzimidazol]​-​1'-​yl)​methyl]​[1,​1'-​biphenyl]​-​2-​carboxylic acid, CAS 144701-48-4
AG001K1T
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 144701-48-4
Catalog Number AG001K1T(AGN-PC-0PW05S)
Chemical Name 4'-​[(1,​4'-​Dimethyl-​2'-​propyl[2,​6'-​bi-​1H-​benzimidazol]​-​1'-​yl)​methyl]​[1,​1'-​biphenyl]​-​2-​carboxylic acid
IUPAC Name 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid
InChI InChI=1S/C33H30N4O2/c1-4-9-30-35-31-21(2)18-24(32-34-27-12-7-8-13-28(27)36(32)3)19-29(31)37(30)20-22-14-16-23(17-15-22)25-10-5-6-11-26(25)33(38)39/h5-8,10-19H,4,9,20H2,1-3H3,(H,38,39)
InChI Key RMMXLENWKUUMAY-UHFFFAOYSA-N
MDL Number MFCD00918125
Molecular Formula C33H30N4O2
Molecular Weight 514.6169
NSC Number 759811
SMILES O=C(C1=CC=CC=C1C2=CC=C(CN3C4=CC(C5=NC6=CC=CC=C6N5C)=CC(C)=C4N=C3CCC)C=C2)O
UNII U5SYW473RQ
Synonyms
4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid, BIBR 277, BIBR-277, Micardis, Pritor, telmisartan, Telmisartan, 144701-48-4, Micardis, Pritor, BIBR 277, Kinzalmono, BIBR 277SE, BIBR-277, 4'-((1,7'-Dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxylic acid, Telmisattan, Targit, Telmisartan [INN], UNII-U5SYW473RQ, BIBR-277SE, BIBR-277-SE, 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid, CHEMBL1017, U5SYW473RQ, CHEBI:9434, C33H30N4O2, MFCD00918125, 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid, 4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid, 4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid, NCGC00095150-01, AK-72892, CPD000466326, DSSTox_CID_3636, DSSTox_RID_77121, DSSTox_GSID_23636, (1,1'-Biphenyl)-2-carboxylic acid, 4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-, [1,1'-Biphenyl]-2-carboxylic acid, 4'-[(1,4'-dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-, 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propyl-benzimidazol-1-yl]methyl]phenyl]benzoic acid, Q-101933, Kinzal, Tazlok, Kinzal/Pritor, Telmisartan [USAN:INN], Micardis (TN), 2-(4-{[4-methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl-1H-1,3-benzodiazol-1-yl]methyl}phenyl)benzoic acid, 4'[(1,4'-DIMETHYL-2'-PROPYL[2,6'-BI-1H-BENZIMIDAZOL]-1'-YL)METHYL][1,1'-BIPHENYL]-2-CARBOXYLIC ACID, SMR000466326, CAS-144701-48-4, Bay 68-9291, SR-01000759355, Temax, HSDB 7590, 4'-[(1,4'-dimethyl-2'-propyl[2,6'-bi-1h-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid, 4'-[[4-METHYL-6-(1-METHYL-2-BENZIMIDAZOLYL)-2-PROPYL-1-BENZIMIDAZOLYL]METHYL]-2-BIPHENYLCARBOXYLIC ACID, Telmisartan [USAN:USP:INN:BAN], YM-086, Telmisartan(Micardis), BAY68-9291, PubChem14979, Telmisartan (Micardis), Spectrum2_001976, Spectrum3_001089, Spectrum4_001261, Spectrum5_001053, AC1L24EB, AC1Q5U7O, SCHEMBL4464, Telmisartan tablets (JP17), BIBR277, BSPBio_002738, GTPL592, KBioGR_001842, MLS000759432, MLS001076687, MLS001424174, MLS006011851, BIBR 277 SE, BIDD:GT0365, SPECTRUM1505261, SPBio_002131, DTXSID8023636, Targit;Temax;BIBR277;Micardis, KBio3_001958, Telmisartan (JP17/USAN/INN), RMMXLENWKUUMAY-UHFFFAOYSA-N, HMS1922P07, HMS2051P16, HMS2090P17, HMS2093M22, HMS2231P07, HMS3393P16, HMS3655C08, HMS3715L17, Pharmakon1600-01505261, ALBB-028954, BCP04513, KS-00000D1K, ZINC1530886, ZX-AN079767, Tox21_111452, BBL029085, BDBM50043280, BG0644, CCG-39514, DL-511, GP9498, NSC759811, s1738, STK624049, AKOS005557501, Telmisartan, >=98% (HPLC), solid, Tox21_111452_1, AB07687, AC-2013, AM90292, API0004337, CS-1699, DB00966, KS-1215, MCULE-8479555254, NC00296, NSC-759811, BAY-68-9291, NCGC00095150-02, NCGC00095150-03, NCGC00095150-04, NCGC00095150-06, NCGC00095150-07, NCGC00095150-08, 4'-((4-mehtyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimmidazolyl)methyl)-2-biphenylcarboxylic acid, 4'-(1,7'-DIMETHYL-2'-PROPYL-1H-[2,5']BIBENZOIMIDAZOLYL-3'-YLMETHYL)-BIPHENYL-2-CARBOXYLIC ACID, 4'-[(1,4'-dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid, 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid, 4CA-1224, AJ-26708, AN-14373, BR-72892, CC-34667, HY-13955, LS-44263, SAM001246602, SC-12741, SY052776, BCP0726000055, SBI-0206733.P001, AB0012010, AB2000262, AX8018372, ST2410854, TL8000991, FT-0631170, SW197676-3, T-170, MFCD00918125 (98%), C07710, D00627, J10282, S-2837, 66930-EP2270011A1, 66930-EP2272841A1, 66930-EP2277866A1, 66930-EP2277879A1, 66930-EP2295406A1, 66930-EP2295422A2, 66930-EP2298772A1, 66930-EP2298779A1, 66930-EP2301923A1, 66930-EP2301931A1, 66930-EP2301936A1, 66930-EP2305219A1, 66930-EP2305650A1, 66930-EP2308839A1, AB00639941-06, AB00639941-07, AB00639941_08, AB00639941_09, 701T484, A808270, C-23026, L001035, I06-0281, SR-01000759355-4, SR-01000759355-5, BRD-K73999723-001-02-2, Z2210710360, Telmisartan, European Pharmacopoeia (EP) Reference Standard, Telmisartan, United States Pharmacopeia (USP) Reference Standard, Telmisartan, Pharmaceutical Secondary Standard; Certified Reference Material, Telmisartan for peak identification, European Pharmacopoeia (EP) Reference Standard, Telmisartan for system suitability, European Pharmacopoeia (EP) Reference Standard, 2-[4-[[4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl]methyl]phenyl]benzoic acid, 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid., 4''-((1,4''-dimethyl-2''-propyl(2,6''-bi-1H-benzimidazol)-1''-yl)methyl)-(1,1''-biphenyl)-2-carboxylic acid, 4''-((4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid, 4''-[(1,4''-dimethyl-2''propyl[2,6''-bi-1H-benzimidazol]-1''-yl)methyl]-[1,1''-biphenyl]-2-carboxylic acid, 4''-[(1,7''-dimethyl-2''-propyl-1H,3''H-2,5''-bibenzimidazol-3''-yl)methyl][1,1''-biphenyl]-2-carboxylic acid, 4''-[(1,7''-dimethyl-2''-propyl-1H,3''H-2,5''-bibenzimidazol-3''-yl)methyl]biphenyl-2-carboxylic acid, 4'-((1,7'-Dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carbox, 4'-((1,7'-DIMETHYL-2'-PROPYL-1H,3'H-2,5'-BIBENZO[D]IMIDAZOL-3'-YL)METHYL)BIPHENYL-2-CARBOXYLIC ACID, 4'-[[2-n-Propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-benzimidazol-1-yl]-methyl]-biphenyl-2-carboxylic acid, 4'-[[4-Methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl]methyl]biphenyl-2-carboxylic Acid, 4'-[2-n-propyl-4-methyl-6-(1-methyl benzimidazol-2-yl)benzimidazol-1-yl methyl]biphenyl-2-carboxylic acid, 4'-{[4-methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl-1H-1,3-benzodiazol-1-yl]methyl}-[1,1'-biphenyl]-2-carboxylic acid, TLS, tolura, Semintra, Micardis HCT, Telmisartan Teva, Telmisartan Actavis, D0N6RF, Abbott brand of telmisartan, Telmisartan (JAN/USAN/INN), Glaxo Wellcome brand of telmisartan, CID65999, GlaxoSmithKline brand of telmisartan, TU-199, C33-H30-N4-O2, ACN-039971, CS-O-02439, Boehringer Ingelheim brand of telmisartan, A8531, T2861, A10905, Micardis, Targit, Temax, BIBR277, Telmisartan, C084178, D000077333,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited